These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2466454)

  • 1. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1989 Mar; 107(3):344-52. PubMed ID: 2466454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of treatment extent on the visual acuity of eyes treated with Krypton laser for juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1995 Feb; 113(2):190-4. PubMed ID: 7532395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1990 Jun; 108(6):825-31. PubMed ID: 1693497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1987 Nov; 105(11):1499-507. PubMed ID: 2445326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Krypton laser photocoagulation for idiopathic neovascular lesions. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1990 Jun; 108(6):832-7. PubMed ID: 1693498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1990 Jun; 108(6):816-24. PubMed ID: 1693496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of recurrent juxtafoveal subretinal neovascular membranes with krypton red laser photocoagulation.
    Olk RJ; Burgess DB
    Ophthalmology; 1985 Aug; 92(8):1035-46. PubMed ID: 2413415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1986 Apr; 104(4):503-12. PubMed ID: 2420315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1994 Apr; 112(4):500-9. PubMed ID: 7512336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1994 Apr; 112(4):489-99. PubMed ID: 7512335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1991 Aug; 109(8):1109-14. PubMed ID: 1714270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1996 Apr; 114(4):400-12. PubMed ID: 8602776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iatrogenic choroidal neovascularization after krypton red laser photocoagulation.
    Orth DH; Flood TP; Packo KH
    Ophthalmic Surg; 1989 Apr; 20(4):273-7. PubMed ID: 2471948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1986 May; 104(5):694-701. PubMed ID: 2423061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of laser treatment in the ocular histoplasmosis syndrome.
    Cummings HL; Rehmar AJ; Wood WJ; Isernhagen RD
    Arch Ophthalmol; 1995 Apr; 113(4):465-8. PubMed ID: 7535999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1995 Jan; 113(1):56-61. PubMed ID: 7529993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis.
    Berger AS; Conway M; Del Priore LV; Walker RS; Pollack JS; Kaplan HJ
    Arch Ophthalmol; 1997 Aug; 115(8):991-6. PubMed ID: 9258220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argon green vs krypton red laser photocoagulation for extrafoveal choroidal neovascularization. One-year results in ocular histoplasmosis. The Canadian Ophthalmology Study Group.
    Arch Ophthalmol; 1994 Sep; 112(9):1166-73. PubMed ID: 7522003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argon laser photocoagulation for ocular histoplasmosis. Results of a randomized clinical trial.
    Arch Ophthalmol; 1983 Sep; 101(9):1347-57. PubMed ID: 6193771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.